Literature DB >> 11925202

Effect of multivalency on the performance of enantioselective separation media for chiral HPLC prepared by linking multiple selectors to a porous polymer support via aliphatic dendrons.

Frank H Ling1, Victor Lu, Frantisek Svec, Jean M J Fréchet.   

Abstract

Chiral stationary phases (CSPs) containing L-proline indananilide chiral selectors attached through a multivalent dendritic linker to monodisperse macroporous poly(2-hydroxyethyl methacrylate-co-ethylene dimethacrylate) beads have been prepared using two different approaches. The convergent method involves the preparation of ligands in solution and their subsequent attachment to the support. The divergent approach is based on the stepwise "on-bead" formation of the linker using methods that are typical of solid-phase synthesis. While the convergent CSPs feature well-defined ligands, their loading is relatively low. In contrast, the divergent technique affords CSPs with higher loading but with more limited control over precise ligand architecture. Excellent enantioselectivities characterized by separation factors of up to 31 were achieved for the separation of racemic N-(3,5-dinitrobenzoyl)-alpha-amino acid alkyl amides with these new CSPs under normal-phase HPLC conditions.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11925202     DOI: 10.1021/jo011005x

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  2 in total

1.  In-column preparation of a brush-type chiral stationary phase using click chemistry and a silica monolith.

Authors:  Michael D Slater; Jean M J Fréchet; Frantisek Svec
Journal:  J Sep Sci       Date:  2009-01       Impact factor: 3.645

2.  Investigation of monovalent and bivalent enantioselective molecular recognition by electrospray ionization-mass spectrometry and tandem mass spectrometry.

Authors:  Kevin A Schug; Manishkumar D Joshi; Petr Frycák; Norbert M Maier; Wolfgang Lindner
Journal:  J Am Soc Mass Spectrom       Date:  2008-07-17       Impact factor: 3.109

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.